Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01826355
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
1ST![]() | (5S,6R,7R,9R)-12-HYDROXY-6-METHOXY- 5-METHYL-7-(METHYLAMINO)-6,7,8,9- TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15- TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4- JKL]CYCLOPENTA[E]-AS-INDACEN-14- ONE | 1 | 2HY8 | 0.75 | ![]() |
090![]() | N-(2,3-DIHYDRO-7,8-DIMETHOXYIMIDAZO[1,2- C] QUINAZOLIN-5-YL)NICOTINAMIDE | A | 2CHX | 0.76 | ![]() |
330![]() | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4- (2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE- 1,3(2H,6H)-DIONE | A | 2IO6 | 0.76 | ![]() |
541![]() | (2R)-N-HYDROXY-2-[(3S)-3-METHYL- 3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}- 2-OXOPYRROLIDIN-1-YL]PROPANAMIDE | A,B | 2FV5 | 0.75 | ![]() |
19B![]() | 4-methyl-N-(3-morpholin-4-ylphenyl)- 3-(3-piperidin-4-yl-1,2-benzisoxazol- 6-yl)benzamide | A | 3E93 | 0.71 | ![]() |
43A![]() | (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)- 3-(1H-PYRROL-2-YLMETHYLENE)-1,3- DIHYDRO-2H-INDOL-2-ONE | A | 2AYP | 0.73 | ![]() |
359![]() | 3-[[3-[(2R)-3-[[(2S)-5-amino-1- [(4-carbamimidoylphenyl)methylamino]- 1,5-dioxo-pentan-2-yl]amino]-2- (ethylsulfonylamino)-3-oxo-propyl]- 1H-indol-5-yl]oxymethyl]benzoic acid | H,L | 2ZZU | 0.72 | ![]() |
3LG![]() | (5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETIC ACID | B | 2G26 | 0.74 | ![]() |
4LG![]() | METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETATE | A,B | 2G27 | 0.74 | ![]() |
3EA![]() | 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL- 6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID | A,B | 2ATH | 0.7 | ![]() |
307![]() | 6,7-DIMETHYL-3-[(METHYL{2-[METHYL({1- [3-(TRIFLUOROMETHYL)PHENYL]-1H- INDOL-3-YL}METHYL)AMINO]ETHYL}AMINO)METHYL]- 4H-CHROMEN-4-ONE | A,C | 2AZ5 | 0.72 | ![]() |
240![]() | (2S)-2-(2-{[1-(4-METHOXYBENZOYL)- 2-METHYL-5-(TRIFLUOROMETHOXY)-1H- INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID | A,B | 2Q59 | 0.73 | ![]() |
447![]() | N-(4-{[6-methoxy-7-(3-morpholin- 4-ylpropoxy)quinazolin-4-yl]amino}phenyl)benzamide | A,B | 2VRX | 0.72 | ![]() |
471![]() | N-((2S)-2-({(1Z)-1-METHYL-3-OXO- 3-[4-(TRIFLUOROMETHYL) PHENYL]PROP- 1-ENYL}AMINO)-3-{4-[2-(5-METHYL- 2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL}PROPYL)PROPANAMIDE | A,B,C,D | 1KKQ | 0.7 | ![]() |
1TQ![]() | 6-(FORMYLAMINO)-7-HYDROXY-L-TRYPTOPHAN | D,H | 2OK6 | 0.71 | ![]() |
1TQ![]() | 6-(FORMYLAMINO)-7-HYDROXY-L-TRYPTOPHAN | D,H | 2I0R | 0.71 | ![]() |
232![]() | 1,3-DI[[[10-METHOXY-7H-PYRIDO[4,3- C]CARBAZOL-2-IUMYL]-ETHYL]-PIPERIDIN- 4-YL]-PROPANE | A | 1C9Z | 0.71 | ![]() |
3CS![]() | 3-[3-(3,3-DIMETHYLBUTANOYL)-1-(4- IODOBENZYL)-5-(QUINOLIN-2-YLMETHOXY)- 1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID | A,B,C,D,E,F | 2Q7R | 0.77 | ![]() |
241![]() | (2S)-2-(3-{[1-(4-METHOXYBENZOYL)- 2-METHYL-5-(TRIFLUOROMETHOXY)-1H- INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID | A,B | 2Q5P | 0.73 | ![]() |
4ST![]() | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 2J0J | 0.71 | ![]() |
4ST![]() | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | B | 2J0M | 0.71 | ![]() |
4ST![]() | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B | 2J0K | 0.71 | ![]() |
4ST![]() | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A | 1YVJ | 0.71 | ![]() |
4ST![]() | 1,2,3,4-TETRAHYDROGEN-STAUROSPORINE | A,B,C | 2HZ4 | 0.71 | ![]() |
4EA![]() | (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)- 2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE | E | 2F7X | 0.7 | ![]() |